article

1. Abnormalities in microbiota/butyrate/FFAR3 signaling in aging gut impair brain function..  JCI insight.  9. 2024
2. Intestinal FFA2 promotes obesity by altering food intake in Western diet-fed mice..  The Journal of endocrinology.  260. 2024
3. A mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut..  Gut.  72:1848-1865. 2023
4. Diet-microbiome-gut-brain nexus in acute and chronic brain injury..  Frontiers in neuroscience.  -. 2022
5. Intestinal FFA3 mediates obesogenic effects in mice on a Western diet..  American journal of physiology. Endocrinology and metabolism.  323:E290-E306. 2022
6. Crosstalk between gut microbiota and lung inflammation in murine toxicity models of respiratory exposure or co-exposure to carbon nanotube particles and cigarette smoke extract..  Toxicology and applied pharmacology.  -. 2022
7. Diabetes and seeds: New horizon to promote human nutrition and anti-diabetics compounds in grains by germination..  Critical reviews in food science and nutrition.  63:1-21. 2022
8. Corrigendum to "Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases"..  Journal of diabetes research.  -. 2022
9. Microbiome in aging of Gut and Brain (MiaGB): paving the ways to understand gut-brain axis in aging..  Aging pathobiology and therapeutics.  4:1-3. 2022
10. Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders..  International journal of molecular sciences.  23. 2022
11. The gut microbiota can be a potential regulator and treatment target of bone metastasis..  Biochemical pharmacology.  -. 2022
12. The Impact of a Mediterranean Diet on the Gut Microbiome in Healthy Human Subjects: A Pilot Study..  Digestion.  103:133-140. 2021
13. Senolytic Combination of Dasatinib and Quercetin Alleviates Intestinal Senescence and Inflammation and Modulates the Gut Microbiome in Aged Mice..  The journals of gerontology. Series A, Biological sciences and medical sciences.  76:1895-1905. 2021
14. Activation of Microbiota Sensing - Free Fatty Acid Receptor 2 Signaling Ameliorates Amyloid-β Induced Neurotoxicity by Modulating Proteolysis-Senescence Axis..  Frontiers in aging neuroscience.  -. 2021
15. Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis..  Cancer research.  81:3890-3904. 2021
16. Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model..  Microbiome.  9:-. 2021
17. Diet-Microbiota-Brain Axis in Alzheimer's Disease..  Annals of nutrition & metabolism.  77 Suppl 2:21-27. 2021
18. Effect of hepcidin antagonists on anemia during inflammatory disorders..  Pharmacology & therapeutics.  -. 2021
19. A Newly Developed Synbiotic Yogurt Prevents Diabetes by Improving the Microbiome-Intestine-Pancreas Axis..  International journal of molecular sciences.  22. 2021
20. New Horizons in Microbiota and Metabolic Health Research..  The Journal of clinical endocrinology and metabolism.  106:e1052-e1059. 2021
21. Health-promoting role of dietary bioactive compounds through epigenetic modulations: a novel prophylactic and therapeutic approach..  Critical reviews in food science and nutrition.  62:619-639. 2020
22. Animal Model To Study Klebsiella pneumoniae Gastrointestinal Colonization and Host-to-Host Transmission..  Infection and immunity.  88. 2020
23. Role of TRP Channels in Shaping the Gut Microbiome..  Pathogens (Basel, Switzerland).  9. 2020
24. Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study..  EBioMedicine.  -. 2020
25. Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods..  Microbial cell factories.  19:-. 2020
26. Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis..  The journals of gerontology. Series A, Biological sciences and medical sciences.  75:e9-e21. 2020
27. Free Fatty Acid Receptors 2 and 3 as Microbial Metabolite Sensors to Shape Host Health: Pharmacophysiological View..  Biomedicines.  8. 2020
28. Unique Gut Microbiome Signatures Depict Diet-Versus Genetically Induced Obesity in Mice..  International journal of molecular sciences.  21. 2020
29. A human-origin probiotic cocktail ameliorates aging-related leaky gut and inflammation via modulating the microbiota/taurine/tight junction axis..  JCI insight.  5. 2020
30. Development of a Novel Oral Delivery Vehicle for Probiotics..  Current pharmaceutical design.  26:3134-3140. 2020
31. Lipoteichoic acid from the cell wall of a heat killed Lactobacillus paracasei D3-5 ameliorates aging-related leaky gut, inflammation and improves physical and cognitive functions: from C. elegans to mice..  GeroScience.  42:333-352. 2019
32. Microbiome-immune-metabolic axis in the epidemic of childhood obesity: Evidence and opportunities..  Obesity reviews : an official journal of the International Association for the Study of Obesity.  21:-. 2019
33. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment..  EBioMedicine.  529-542. 2019
34. An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota..  Journal of visualized experiments : JoVE.  2019
35. Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans..  Scientific reports.  9:-. 2019
36. Probiotics and Prebiotics for the Amelioration of Type 1 Diabetes: Present and Future Perspectives..  Microorganisms.  7. 2019
37. Prebiotics from acorn and sago prevent high-fat-diet-induced insulin resistance via microbiome-gut-brain axis modulation..  The Journal of nutritional biochemistry.  1-13. 2019
38. Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients..  Cancer medicine.  8:1110-1123. 2019
39. Bi-directional drug-microbiome interactions of anti-diabetics..  EBioMedicine.  591-602. 2018
40. Comparative Microbiome Signatures and Short-Chain Fatty Acids in Mouse, Rat, Non-human Primate, and Human Feces..  Frontiers in microbiology.  -. 2018
41. Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity..  Frontiers in microbiology.  -. 2018
42. Obesity-Linked Gut Microbiome Dysbiosis Associated with Derangements in Gut Permeability and Intestinal Cellular Homeostasis Independent of Diet..  Journal of diabetes research.  -. 2018
43. Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome..  Scientific reports.  8:-. 2018
44. TGF-β receptor 1 regulates progenitors that promote browning of white fat..  Molecular metabolism.  160-171. 2018
45. Gut microbiome and aging: Physiological and mechanistic insights..  Nutrition and healthy aging.  4:267-285. 2018
46. Gut Microbiome Composition in Non-human Primates Consuming a Western or Mediterranean Diet..  Frontiers in nutrition.  -. 2018
47. BIOAVAILABILITY OF BIOTRANSFORMED ZINC ENRICHED DAHI IN WISTAR RATS..  International journal of probiotics & prebiotics.  13:45-54. 2018
48. Dietary Polysaccharides in the Amelioration of Gut Microbiome Dysbiosis and Metabolic Diseases..  Obesity & control therapies : open access.  4. 2017
49. Bacterial Translocation from the Gut to the Distant Organs: An Overview..  Annals of nutrition & metabolism.  11-16. 2017
50. PROBIOTICS - A PROBABLE THERAPEUTIC AGENT FOR SPONDYLOARTHROPATHY..  International journal of probiotics & prebiotics.  12:57-68. 2017
51. Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma..  Cellular & molecular biology letters.  -. 2017
52. Interplay between Oxidative Stress and Metabolism in Signalling and Disease 2016..  Oxidative medicine and cellular longevity.  -. 2017
53. TGF-β1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis..  The Journal of biological chemistry.  292:3420-3432. 2017
54. Identification of Guanosine 5'-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway..  Scientific reports.  -. 2017
55. Novel Browning Agents, Mechanisms, and Therapeutic Potentials of Brown Adipose Tissue..  BioMed research international.  -. 2016
56. Whole Grains in Amelioration of Metabolic Derangements..  Journal of nutritional health & food science.  4:1-11. 2016
57. Increased fecal viral content associated with obesity in mice..  World journal of diabetes.  7:316-20. 2016
58. Interplay between Oxidative Stress and Metabolism in Signalling and Disease..  Oxidative medicine and cellular longevity.  -. 2016
59. PROBIOTIC APPROACHES FOR TARGETING INFLAMMATORY BOWEL DISEASE: AN UPDATE ON ADVANCES AND OPPORTUNITIES IN MANAGING THE DISEASE..  International journal of probiotics & prebiotics.  11:99-116. 2016
60. Gut microbiota in health and disease: an overview focused on metabolic inflammation..  Beneficial microbes.  7:181-94. 2015
61. Potential of Alginate Encapsulated Ferric Saccharate Microemulsions to Ameliorate Iron Deficiency in Mice..  Biological trace element research.  172:179-192. 2015
62. Dietary fatty acids: Friends or foes?.  Obesity (Silver Spring, Md.).  23:-. 2015
63. Probiotics as potential antioxidants: a systematic review..  Journal of agricultural and food chemistry.  63:3615-26. 2015
64. Gut microbiota: the next-gen frontier in preventive and therapeutic medicine?.  Frontiers in medicine.  -. 2014
65. Iron supplementation in young iron-deficient females causes gastrointestinal redox imbalance: protective effect of a fermented nutraceutical..  Journal of biological regulators and homeostatic agents.  28:53-63. 2014
66. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion..  The Journal of biological chemistry.  288:25088-25097. 2013
67. A sturgeon-derived bioactive compound beneficially modulates nuclear receptors controlling metabolic functions in patients with metabolic syndrome..  Acta bio-medica : Atenei Parmensis.  84:53-60. 2013
68. Distribution of airborne microbes and antibiotic susceptibility pattern of bacteria during Gwalior trade fair, Central India..  Journal of the Formosan Medical Association = Taiwan yi zhi.  114:639-46. 2013
69. Herbo-probiotic therapy in cardioprotection: a new way of nature to nurture..  Nutrition (Burbank, Los Angeles County, Calif.).  29:1070-1. 2013
70. Impact of obesity and diabetes on arthritis: An update..  Health.  5:143-156. 2013
71. Anti-diabetic compounds and their patent information: an update..  Recent patents on inflammation & allergy drug discovery.  7:35-48. 2013
72. Beneficial effect of a symbiotic preparation with S. boulardii lysate in mild stress-induced gut hyper-permeability..  Acta bio-medica : Atenei Parmensis.  83:208-16. 2012
73. Immune system and gut flora interactions are important episodes in metabolic diseases..  Journal of gastrointestinal and liver diseases : JGLD.  21:347-8. 2012
74. Targeted cancer therapies: the future of cancer treatment..  Acta bio-medica : Atenei Parmensis.  83:220-33. 2012
75. Genotoxic Potential of Reactive Oxygen Species (Ros), Lipid Peroxidation and DNA Repair Enzymes (Fpg and Endo III) in Alloxan Injected Diabetic Rats..  Endocrine, metabolic & immune disorders drug targets.  2012
76. Evaluation of micronuclei induction capacity and mutagenicity of organochlorine and organophosphate pesticides..  Drug metabolism letters.  6:187-97. 2012
77. Improving sperm quality and spermatogenesis through a bioactive marine compound: an experimental study..  Acta bio-medica : Atenei Parmensis.  83:108-13. 2012
78. Inhibiting insulin resistance mechanisms by DTS phytocompound: an experimental study on metabolic syndrome-prone adipocytes..  Acta bio-medica : Atenei Parmensis.  83:95-102. 2012
79. Probiotics, their health benefits and applications for developing healthier foods: a review..  FEMS microbiology letters.  334:1-15. 2012
80. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases..  Experimental diabetes research.  -. 2012
81. Biomarine extracts significantly protect from ultraviolet A-induced skin photoaging: an ex vivo study..  Rejuvenation research.  15:157-60. 2012
82. Cardioprotective effect of a biofermented nutraceutical on endothelial function in healthy middle-aged subjects..  Rejuvenation research.  15:178-81. 2012
83. Functional foods in genomic medicine: a review of fermented papaya preparation research progress..  Acta bio-medica : Atenei Parmensis.  83:21-9. 2012
84. TGF-β/Smad3 Signaling Regulates Brown Adipocyte Induction in White Adipose Tissue..  Frontiers in endocrinology.  -. 2012
85. Fermentation Technology in the Development of Functional Foods for Human Health: Where We Should Head..  Fermentation technology.  1. 2012
86. Beneficial effect of a sturgeon-based bioactive compound on gene expression of tumor necrosis factor-alpha, matrix metalloproteinases and type-10 collagen in human chondrocytes..  Journal of biological regulators and homeostatic agents.  26:337-45. 2012
87. Effective properties of a sturgeon-based bioactive compound on stress-induced hippocampal degeneration and on in vitro neurogenesis..  Journal of biological regulators and homeostatic agents.  26:327-35. 2012
88. Is there a potential application of a fermented nutraceutical in acute respiratory illnesses? An in-vivo placebo-controlled, cross-over clinical study in different age groups of healthy subjects..  Journal of biological regulators and homeostatic agents.  26:285-94. 2012
89. Milk, milk products, and disease free health: an updated overview..  Critical reviews in food science and nutrition.  52:321-33. 2012
90. Probiotics Mediated Modulation of Gut-Flora Might Be a Biotherapeutical Approach for Obesity and Type 2 Diabetes..  Metabolomics : open access.  1. 2011
91. Exotic Fruits as Therapeutic Complements for Diabetes, Obesity and Metabolic Syndrome..  Food research international (Ottawa, Ont.).  44:1856-1865. 2011
92. Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling..  Cell metabolism.  14:67-79. 2011
93. RB regulates pancreas development by stabilizing Pdx1..  The EMBO journal.  30:1563-76. 2011
94. Beneficial nutraceutical modulation of cerebral erythropoietin expression and oxidative stress: an experimental study..  Journal of biological regulators and homeostatic agents.  25:187-94. 2011
95. Bioactive peptides derived from milk proteins and their health beneficial potentials: an update..  Food & function.  2:18-27. 2010
96. Medicinal and biological potential of pumpkin: an updated review..  Nutrition research reviews.  23:184-90. 2010
97. Anti-allergic effects of probiotic Dahi through modulation of the gut immune system..  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.  21:244-50. 2010
98. Biotechnological advancement in isolation of anti-neoplastic compounds from natural origin: a novel source of L-asparaginase..  Acta bio-medica : Atenei Parmensis.  81:104-8. 2010
99. Cancer-preventing attributes of probiotics: an update..  International journal of food sciences and nutrition.  61:473-96. 2010
100. Progression of atherosclerotic lesions in the arteries and related gene expression: protective effect of phytonutrients..  Rejuvenation research.  13:242-5. 2010
101. Protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes..  Journal of biological regulators and homeostatic agents.  24:41-9. 2010
102. Subclinical candiduria in patients with gastrointestinal malignancies: a preliminary study on the protective effect of a natural phytocompound..  Journal of biological regulators and homeostatic agents.  24:317-24. 2010
103. Complementary and comparative study on hypoglycemic and antihyperglycemic activity of various extracts of Eugenia jambolana seed, Momordica charantia fruits, Gymnema sylvestre, and Trigonella foenum graecum seeds in rats..  Applied biochemistry and biotechnology.  160:2388-400. 2009
104. Antioxidant and cholesterol assimilation activities of selected lactobacilli and lactococci cultures..  The Journal of dairy research.  76:385-91. 2009
105. Biological and medicinal properties of grapes and their bioactive constituents: an update..  Journal of medicinal food.  12:473-84. 2009
106. Probiotic dahi containing Lactobacillus casei protects against Salmonella enteritidis infection and modulates immune response in mice..  Journal of medicinal food.  12:576-83. 2009
107. Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function..  The Journal of biological chemistry.  284:12246-57. 2009
108. Epigenomic derangement of hepatic glucose metabolism by feeding of high fructose diet and its prevention by Rosiglitazone in rats..  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.  41:500-8. 2009
109. Inhibition of human breast cancer cell growth and enzymatic activity by a fermented nutraceutical: an in vitro and in vivo study ..  Annals of the New York Academy of Sciences.  273-7. 2009
110. Modulation of cytokine gene expression in spleen and Peyer's patches by feeding dahi containing probiotic Lactobacillus casei in mice..  Journal of digestive diseases.  10:49-54. 2009
111. Protective effect of a phytocompound on oxidative stress and DNA fragmentation against paracetamol-induced liver damage..  Annals of hepatology.  8:50-6. 2009
112. Innate and specific gut-associated immunity and microbial interference..  FEMS immunology and medical microbiology.  55:6-12. 2008
113. Stimulation of innate immunity by oral administration of dahi containing probiotic Lactobacillus casei in mice..  Journal of medicinal food.  11:652-6. 2008
114. Molecular approaches for identification and characterization of lactic acid bacteria..  Journal of digestive diseases.  9:190-8. 2008
115. Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats..  The Journal of dairy research.  75:189-95. 2008
116. The effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei on gastropathic consequences in diabetic rats..  Journal of medicinal food.  11:62-8. 2008
117. Antimicrobial property of a herbal preparation containing Dalbergia sissoo and Datura tramonium with cow urine against pathogenic bacteria..  International journal of immunopathology and pharmacology.  21:1013-20. 2008
118. Dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei has a protective effect against Salmonella enteritidis infection in mice..  International journal of immunopathology and pharmacology.  21:1021-9. 2008
119. Effect of modified alkaline supplementation on bone metabolic turnover in rats..  Journal of biological regulators and homeostatic agents.  22:225-31. 2008
120. Preventive effect of diabegon, a polyherbal preparation, during progression of diabetes induced by high-fructose feeding in rats..  Journal of pharmacological sciences.  105:12-21. 2007
121. Subjects with impaired glucose tolerance exhibit a high degree of tolerance to honey..  Journal of medicinal food.  10:473-8. 2007
122. Formation of oligosaccharides in skim milk fermented with mixed dahi cultures, Lactococcus lactis ssp diacetylactis and probiotic strains of lactobacilli..  The Journal of dairy research.  74:154-9. 2007
123. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats..  Nutrition (Burbank, Los Angeles County, Calif.).  23:62-8. 2006
124. Effect of Dahi containing Lactococcus lactis on the progression of diabetes induced by a high-fructose diet in rats..  Bioscience, biotechnology, and biochemistry.  70:1255-8. 2006
125. Effect of skim milk and dahi (yogurt) on blood glucose, insulin, and lipid profile in rats fed with high fructose diet..  Journal of medicinal food.  9:328-35. 2006
126. Internet resources for diabetes..  Indian journal of medical sciences.  59:32-42. 2005